Breast cancer stem cells, pathways and therapeutic perspectives 2011

Area of Science:

• Oncology
• Stem Cell Biology
• Molecular Biology

Background:

• Cancer stem cells (CSCs) are implicated in tumor initiation, maintenance, and heterogeneity across various cancers.
• Normal human mammary stem cells have been purified, supporting models where breast tumor heterogeneity reflects CSC-like populations.
• Key stem cell properties include self-renewal and regulated differentiation, crucial for tissue homeostasis.

Purpose of the Study:

• To review methodologies for characterizing epithelial stem cells and identifying tumorigenic cells in breast cancer.
• To explore the role of signaling pathways (Hedgehog, Wnt/β-catenin, Notch) in mammary stem cell regulation.
• To discuss therapeutic strategies targeting breast cancer stem cells (BCSCs).

Main Methods:

• Characterization of stem cells using markers, mammosphere formation assays, side population analysis, and radionuclide retention.
• Identification of tumorigenic cells within breast cancers.
• Analysis of signaling pathways involved in stem cell self-renewal and differentiation.

Main Results:

• Evidence supports a heterogeneous population of CSCs responsible for tumor initiation and maintenance.
• Mammosphere formation and other assays effectively characterize stem cells and identify tumorigenic cells.
• Signaling pathways like Hedgehog, Wnt, and Notch are critical for mammary stem cell regulation.

Conclusions:

• Targeting BCSCs holds significant therapeutic potential for breast cancer treatment.
• Therapeutic strategies include chemotherapy sensitization, differentiation therapy, and targeting signaling pathways.
• Inhibiting BCSCs, especially those capable of metastasis, is crucial for reducing cancer morbidity and mortality.